For individuals living with Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a serious condition, the arrival of this treatment and the formulated version represents a true change. These groundbreaking therapies preserve the transthyretin protein, slowing its harmful build-up and reducing the burden of the disease . Individuals are now reporting … Read More